BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15963597)

  • 1. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1.
    Cheng J; Imanishi H; Morisaki H; Liu W; Nakamura H; Morisaki T; Hada T
    J Hepatol; 2005 Sep; 43(3):465-71. PubMed ID: 15963597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line.
    Oquendo J; Dubanchet S; Capel F; Mabit H; Petit MA
    Eur Cytokine Netw; 1996 Dec; 7(4):793-800. PubMed ID: 9010683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts.
    Zhang Z; Andoh A; Inatomi O; Bamba S; Takayanagi A; Shimizu N; Fujiyama Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):619-27. PubMed ID: 15836713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma.
    Endo T; Ogushi F; Sone S
    J Immunol; 1996 Mar; 156(6):2240-6. PubMed ID: 8690914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of cyclooxygenase-II gene and PGE2 production of peritoneal macrophages in diabetic rats.
    Lo CJ
    J Surg Res; 2005 May; 125(2):121-7. PubMed ID: 15854663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclooxygenase-2 expression in human osteoblastic cells by N-acetylcysteine.
    Origuchi T; Migita K; Nakashima T; Honda S; Yamasaki S; Hida A; Kawakami A; Aoyagi T; Kawabe Y; Eguchi K
    J Lab Clin Med; 2000 Nov; 136(5):390-4. PubMed ID: 11079466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ent-pimara-8(14), 15-dien-19-oic acid isolated from the roots of Aralia cordata inhibits induction of inflammatory mediators by blocking NF-kappaB activation and mitogen-activated protein kinase pathways.
    Kang OH; Chae HS; Choi JG; Oh YC; Lee YS; Kim JH; Seung MJ; Jang HJ; Bae KH; Lee JH; Shin DW; Kwon DY
    Eur J Pharmacol; 2008 Dec; 601(1-3):179-85. PubMed ID: 18938152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effect of LPS and feedback effect of PGE2 on IL-27 production.
    Zhu CL; Cao YH; Zhang R; Song Y; Liu WY; Pan F; Li Y; Zhu Y; Liu F; Wu JG
    Scand J Immunol; 2010 Dec; 72(6):469-75. PubMed ID: 21044121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytes respond to lipopolysaccharide through Toll-like receptor-4, and MAP kinase and NF-kappaB pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2.
    Scott T; Owens MD
    Mol Immunol; 2008 Feb; 45(4):1001-8. PubMed ID: 17825413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells.
    Lappas M; Yee K; Permezel M; Rice GE
    Placenta; 2006; 27(6-7):568-75. PubMed ID: 16122789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages.
    Shibata Y; Nishiyama A; Ohata H; Gabbard J; Myrvik QN; Henriksen RA
    J Leukoc Biol; 2005 Apr; 77(4):544-51. PubMed ID: 15657087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation.
    Shin KM; Shen L; Park SJ; Jeong JH; Lee KT
    J Pharm Pharmacol; 2009 Apr; 61(4):479-86. PubMed ID: 19298695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14.
    Huang JR; Wu CC; Hou RC; Jeng KC
    Immunol Invest; 2008; 37(4):263-77. PubMed ID: 18569070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibitory effects of furonaphthoquinone compound on enzyme activity and lipopolysaccharide-induced expression of cyclooxygenase-2 in macrophages.
    Ahn KY; Kim BH; Lee YR; Hwang DH; Chung EY; Min KR; Kim Y
    Biochem Biophys Res Commun; 2005 Oct; 336(1):93-9. PubMed ID: 16125137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways.
    Li XY; He JL; Liu HT; Li WM; Yu C
    J Ethnopharmacol; 2009 Aug; 125(1):83-9. PubMed ID: 19540326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation.
    Kojima M; Morisaki T; Izuhara K; Uchiyama A; Matsunari Y; Katano M; Tanaka M
    Oncogene; 2000 Feb; 19(9):1225-31. PubMed ID: 10713711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) attenuates LPS-induced IL-8 expression by decreasing mRNA stability in THP-1 cells.
    Im J; Kang SS; Yang JS; Yun CH; Yang Y; Han SH
    Toxicol Lett; 2008 Mar; 177(2):108-15. PubMed ID: 18281166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupivacaine inhibits COX-2 expression, PGE2, and cytokine production in endotoxin-activated macrophages.
    Huang YH; Tsai PS; Huang CJ
    Acta Anaesthesiol Scand; 2008 Apr; 52(4):530-5. PubMed ID: 18339158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-kappaB pathway.
    Hseu YC; Wu FY; Wu JJ; Chen JY; Chang WH; Lu FJ; Lai YC; Yang HL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1914-25. PubMed ID: 16275626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.